A review article focusing on the Drug Discovery and Development platform has been published in Drug Discovery Today. The article describes the origin of the platform as well as it’s purpose and structure.

Highlights

  • SciLifeLab DDD platform reaches out to Swedish academia with an industry-standard infrastructure for academic drug discovery.
  • The Swedish Teacher Exemption Law, an internationally unique aspect of the innovation system, has shaped the operation.
  • SciLifeLab DDD facilitates international collaboration between academia and industry.

Read the full review: doi:10.1016/j.drudis.2016.06.026

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.